Dong-A ST Co., Ltd. (KRX:170900)

Market Cap	422.71B
Revenue (ttm)	697.87B
Net Income (ttm)	-1.22B
Shares Out	9.16M
EPS (ttm)	-141.41
PE Ratio	n/a
Forward PE	10.68
Dividend	686.27 (1.46%)
Ex-Dividend Date	Mar 13, 2025

Volume	16,398
Average Volume	16,871
Open	47,000
Previous Close	47,000
Day's Range	45,800 - 47,000
52-Week Range	40,900 - 79,118
Beta	0.49
RSI	51.72
Earnings Date	Apr 25, 2025

About Dong-A ST

Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products in South Korea and internationally. It offers various ethical drugs, including Closerin Cap for active pulmonary and extra-pulmonary tuberculosis; Dulastin PFS and Leucostim injection/PFS to treat neutropenia in patients receiving myelosuppressive chemotherapy; Eporon inj./PFS for anemia associated with chronic renal failure; Gemcit inj. to treat non-small cell lung, pancreatic, breast, bladder, and ovarian cancers; Gonadopin inj./PFS for infertility and anovulation...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1932
• Employees: 1,687
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 170900